82 related articles for article (PubMed ID: 12542913)
41. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
Uckun FM; Morar S; Qazi S
Br J Haematol; 2006 Nov; 135(4):500-8. PubMed ID: 17061978
[TBL] [Abstract][Full Text] [Related]
42. Assessment of sperm apoptosis in cryopreserved bull semen after swim-up treatment: a flow cytometric study.
Chaveiro A; Santos P; da Silva FM
Reprod Domest Anim; 2007 Feb; 42(1):17-21. PubMed ID: 17214767
[TBL] [Abstract][Full Text] [Related]
43. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
Ferrer A; Marcé S; Bellosillo B; Villamor N; Bosch F; López-Guillermo A; Espinet B; Solé F; Montserrat E; Campo E; Colomer D
Oncogene; 2004 Nov; 23(55):8941-9. PubMed ID: 15480431
[TBL] [Abstract][Full Text] [Related]
44. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
45. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia].
Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684
[TBL] [Abstract][Full Text] [Related]
46. [6-Mercaptopurine and methotrexate, rational use in sight after 35 years?].
Bökkerink JP; Schouten TJ; De Abreu RA; Lippens RJ; De Vaan GA; De Bruyn CH; Van Laarhoven JP
Tijdschr Kindergeneeskd; 1984 Aug; 52(4):118-23. PubMed ID: 6593896
[TBL] [Abstract][Full Text] [Related]
47. Purine metabolism as a target for leukemia chemotherapy.
Riscoe MK; Brouns MC; Fitchen JH
Blood Rev; 1989 Sep; 3(3):162-73. PubMed ID: 2676034
[TBL] [Abstract][Full Text] [Related]
48. Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs.
Tsurusawa M; Saeki K; Fujimoto T
Int J Hematol; 1997 Jul; 66(1):79-88. PubMed ID: 9220663
[TBL] [Abstract][Full Text] [Related]
49. Thiopurines, DNA damage, DNA repair and therapy-related cancer.
Karran P
Br Med Bull; 2006; 79-80():153-70. PubMed ID: 17277075
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay.
Pieters R; Huismans DR; Leyva A; Veerman AJ
Adv Exp Med Biol; 1989; 253A():447-54. PubMed ID: 2624225
[No Abstract] [Full Text] [Related]
51. [Effect of Methotrexate on Cell Growth of Human Monocyte-like Cell Line U937 and Its Induction of Apoptosis].
Ye H; Gu L; Chen H; Chen J; Ye Y; Bian J; Xue H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Mar; 8(1):43-47. PubMed ID: 12578717
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy of leukaemia. II. 6-Mercaptopurine (purinethol) in the treatment of acute leukaemia and some other neoplastic diseases of the reticuloendothelial system.
GREIG HB; METZ J; LAIRD MH; ZENTKOWSKY D; FITZPATRICK MM
S Afr Med J; 1956 Apr; 30(15):360-3. PubMed ID: 13324392
[No Abstract] [Full Text] [Related]
53. Acute leukaemia in adults treated with 6-mercaptopurine.
WHITELAW DM; MOFFAT RG; PERRY WH; BECK RE
Can Med Assoc J; 1956 Mar; 74(6):423-6. PubMed ID: 13304781
[No Abstract] [Full Text] [Related]
54. 6-Mercaptopurine in acute leukaemia.
HAYHOE FG
Lancet; 1955 Oct; 269(6896):903-5. PubMed ID: 13264641
[No Abstract] [Full Text] [Related]
55. Treatment of leukaemia and allied disorders with 6-mercaptopurine.
FOUNTAIN JR
Br Med J; 1955 May; 1(4922):1119-24. PubMed ID: 14363808
[No Abstract] [Full Text] [Related]
56. Sir Hans A. Krebs Centenary Lecture: cancer and clinical targeting.
Weber G
Adv Enzyme Regul; 2001; 41():1-29. PubMed ID: 11417529
[No Abstract] [Full Text] [Related]
57. Low-protein purine-free diet in treatment of acute leukaemia in children: preliminary communication.
Halikowski B; Armata J; Garwicz S
Br Med J; 1966 Feb; 1(5486):519-21. PubMed ID: 5902697
[No Abstract] [Full Text] [Related]
58. The mechanism of Renshen-Fuzi herb pair for treating heart failure-Integrating a cardiovascular pharmacological assessment with serum metabolomics.
Chen X; Chen Y; Xie S; Wang X; Wu Y; Zhang H; Zhao Y; Jia J; Wang B; Li W; Tang J; Xiao X
Front Pharmacol; 2022; 13():995796. PubMed ID: 36545315
[No Abstract] [Full Text] [Related]
59. 6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Flesner BK; Kumar SR; Bryan JN
BMC Vet Res; 2014 Dec; 10():290. PubMed ID: 25480665
[TBL] [Abstract][Full Text] [Related]
60. Combination therapy in childhood leukaemia: in vitro studies of thiopurines and inhibitors of purine metabolism on apoptosis.
De Abreu RA; Trueworthy RC; van Kuilenburg AB; Vogels-Mentink TM; Lambooy LH; van Gennip AH
Ann Clin Biochem; 2003 Jan; 40(Pt 1):70-4. PubMed ID: 12542913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
